Preferred Label : Drug Development;
NCIt definition : Design, identification, synthesis, extraction, purification, modification, or characterization
of potential anticancer agents; studies of their metabolism, distribution, excretion,
physiological effects, molecular interactions, structural analysis, toxicity, mechanism
of action, antitumor effects in vivo (nonhuman species) or in vitro (human or nonhuman),
and phase I and phase II clinical trials.;
Origin ID : C15760;
UMLS CUI : C0872152;
Automatic exact mappings (from CISMeF team)
- Semantic type(s)
- UMLS correspondences (same concept)
